Company intelligence / Profile preview

Haisan Pharmaceutical Technology

Dongyang, Zhejiang, Chinahaisenpharma.com ↗

Ownership: Private
Employees: ~450
Development stage: Phase 3

Overview

Zhejiang Haisen Pharmaceutical has over two decades of experience as a high-tech enterprise specializing in R&D, production and sales of chemical active pharmaceutical ingredients and intermediates. Its portfolio includes more than thirty commercialized products with a focus on digestive system drugs, antipyretics/analgesics, and cardiovascular agents. The company has received multiple local industry awards for its contributions to industrial development.

Therapeutic areas: GastroenterologyPsychiatryCardiovascularRheumatology
Modalities: Small moleculeChemical drug (API)
Industry: Chemicals & Materials

Drug pipeline

2 assets

escitalopram oxalate

Commercial

Indications: Depression

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Haisan Pharmaceutical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haisan Pharmaceutical Technology.

Explore the full profile